Long-Term Clinical Outcomes of the 0.18 Mg Fluocinolone Acetonide Intravitreal Implant Following Local Corticosteroid Burst in Noninfectious Uveitis

CONCLUSIONS: This treatment approach demonstrates that the 0.18 mg FAi is a useful adjuvant for the treatment of noninfectious uveitis but may not be adequate as solo therapy.PMID:38194443 | DOI:10.1080/09273948.2023.2296031

Source: Ocular Immunology and Inflammation - January 9, 2024 Category: Allergy & Immunology Authors: Timothy M Janetos Anjum Koreishi Debra A Goldstein Source Type: research